Baby with genetic OTC deficiency shows promising response to iECURE's first-in-kind gene therapy, potentially avoiding liver ...

Revance Therapeutics said Wednesday it will have talks with Teoxane on its bid to take over Revance's company. But Crown ...

Pfizer and GSK’s RSV vaccines have a new warning at the request of the FDA, relaying an increased risk to Guillain-Barré ...

National Resilience is laying off 120 staffers from its gene therapy facility in North Carolina, only a month after the San ...

Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.

A new startup aiming to tackle rare diseases de-stealthed Wednesday morning with a CEO experienced in the space. Alesta ...

Roche's Chugai partners with Araris Biotech on multi-payload ADCs, as Swiss biotech advances tech allowing multiple cytotoxic ...

Tenvie Therapeutics launches with $200M, acquires Denali drug candidates, led by Tony Estrada with NLRP3 and SARM1 inhibitors ...

Aspect Biosystems raises $115M Series B for bioprinted tissue therapeutics targeting diabetes and metabolic disorders, led by ...

Ahead of the busiest week for biopharma dealmaking at the annual JP Morgan Healthcare Conference, a new startup launched, ...

Vir Biotechnology reports early data on T cell engagers VIR-5818 and VIR-5500, licensed from Sanofi, showing tumor shrinkage ...

A private startup looking to bring an old schizophrenia drug class to the US has released new Phase 2 data and aims to start ...